knowledge -WSS

knowledge

author：explore 2025-09-28 02:47:39 - browse：595

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： A letter from the executive editor: The 2023 STATUS List

Wikipedia

WSS

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

2 officers injured in shooting in Orlando, police say

What affirmative action's end means to a medical student

2 officers injured in shooting in Orlando, police say

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

explore

knowledge

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

How to save PrEP access — and even expand it

Hubble vs. James Webb telescope images: See the difference

Medicare proposal to cover medical devices draws a mixed reaction

Flint parents haunted by uncertainty, fears of lead poisoning

ChatGPT in medicine: STAT answers readers' burning questions

Use doctors trained outside the U.S. to ease the physician shortage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

focus

UpToDate has a racism problem: Dr. Stanley Goldfarb

Beware reading your test results before your doctor does

Biotech startup Celsius cuts 75% of staff ahead of first trial start

The a glaring gap in research on serious mental illness and primary care

Dexcom's push to bring CGM to type 2 diabetes patients

2 officers injured in shooting in Orlando, police say

leisure time

hotspot

Wikipedia

explore